Oligo-basic amino acids, potential nicotinic acetylcholine receptor inhibitors

Area of Science:

• Molecular Biology
• Pharmacology
• Neuroscience

Background:

• Oligo-basic amino acids are well-studied but their inhibitory effects on nicotinic acetylcholine receptors (nAChRs) were previously unknown.
• Nicotinic acetylcholine receptors (nAChRs) are crucial targets in various physiological and pathological processes.

Purpose of the Study:

• To investigate the inhibitory activity of various oligopeptides on different nAChR subtypes.
• To identify potential lead compounds for selective nAChR inhibition.

Main Methods:

• Evaluated 8 oligopeptides, including oligo-lysines and oligo-arginines, on 9 nAChR subtypes.
• Utilized two-electrode voltage clamp (TEVC) electrophysiology.
• Performed flexible docking simulations to understand binding interactions.

Main Results:

• Oligo-lysines (K9, K12, d-K9, d-K9F) and oligo-arginine (R9) exhibited nanomolar inhibitory activity against nAChRs, especially α7 and α9α10 subtypes.
• The modified oligo-lysine d-K9F showed significantly enhanced inhibition, including a 47-fold increase on α1β1δε nAChR.
• Molecular docking revealed strong dipole-dipole interactions between K9 and nAChR binding pockets.

Conclusions:

• Oligo-basic amino acids, particularly oligo-lysines, demonstrate significant potential as selective nAChR inhibitors.
• Further modification of oligo-lysines could lead to optimized therapeutic agents.
• Consideration of toxicity and side effects is crucial for future applications.